We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02586207
Title Pembrolizumab in Combination With CRT for LA-SCCHN
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sanford Health
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UCSD Moores Cancer Center La Jolla California 92093-0698 United States Details
Sanford-Bismarck Medical Center Bismarck North Dakota 58501 United States Details
Sanford-Roger Maris Cancer Center Fargo North Dakota 58122 United States Details
Sanford Health Cancer Center Sioux Falls South Dakota 57104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field